Lung cancer is the primary cause of cancer mortality in developed countries. First diagnosis only when disease has already reached the metastatic phase is the main reason for failure in treatment. To this regard, although low-dose spiral computed tomography (CT) has proven to be effective in the early detection of lung cancer (providing both higher ...
openaire +2 more sources
Background: Lung cancer screening is not limited to low dose computed tomography (LDCT). Recently, molecular biomarkers have been shown to have the potential to improve the current state of early lung cancer detection.
Fan Ren MD +9 more
doaj +1 more source
Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling [PDF]
Z-M Shi +14 more
openalex +1 more source
From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with Immunotherapy [PDF]
Andrea Sesma +14 more
openalex +1 more source
Pharmacological Strategies in Lung Cancer-Induced Cachexia: Effects on Muscle Proteolysis, Autophagy, Structure, and Weakness [PDF]
Alba Chacon‐Cabrera +7 more
openalex +1 more source
Chinese Anti-Cancer Association, Lung Cancer Study Group of Committee of Oncopathology +2 more
doaj +1 more source
Angelo Borsarelli Carvalho Brito +2 more
openalex +1 more source
The Profile and Clinical Significance of ITGB2 Expression in Non-Small-Cell Lung Cancer [PDF]
Lingling Zu +8 more
openalex +1 more source
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival [PDF]
Patrick Kellish +16 more
openalex +1 more source

